Hypofractionated Stereotactic Radiotherapy With Anlotinib in Patients With Recurrent High-Grade Gliomas

Condition:   Malignant Glioma Interventions:   Radiation: Hypofractionated Stereotactic Radiotherapy;   Drug: Anlotinib Sponsor:   Huashan Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials